< 110 > Industry - Academic Cooperation Foundation , Yonsei University < 120 > A composition for preventing , improving or treating for cancer < 130 > PDPB 194090 d 01 < 160 > 24 < 170 > KoPatentIn 3 . 0 < 210 > 1 < 211 > 17 < 212 > RNA < 213 > Artificial Sequence < 220 > < 223 > miR - 4516 < 400 > 1 gggagaaggg ucggggc 17 < 210 > 2 < 211 > 17 < 212 > RNA < 213 > Artificial Sequence < 220 > < 223 > miR - 4516 < 400 > 2 cccgacccuu cucccuu 17 < 210 > 3 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 132 - 3 p forward primer < 400 > 3 taacagtcta cagccatggt 20 < 210 > 4 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 132 - 3 p reverse primer < 400 > 4 aacgagacga cgacagactt t 21 < 210 > 5 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 199 b - 5 p forward primer < 400 > 5 cccagtgttt agactatctg 20 < 210 > 6 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 199 b - 5 p reverse primer < 400 > 6 aacgagacga cgacagactt t 21 < 210 > 7 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 29 b - 3 p forward primer < 400 > 7 tagcaccatt tgaaatcagt 20 < 210 > 8 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 29 b - 3 p reverse primer < 400 > 8 aacgagacga cgacagactt t 21 < 210 > 9 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 1253 forward primer < 400 > 9 agagaagaag atcagcctgc 20 < 210 > 10 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 1253 reverse primer < 400 > 10 aacgagacga cgacagactt t 21 < 210 > 11 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 1915 forward primer < 400 > 11 ccccagggcg acgcggcggg 20 < 210 > 12 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 1915 reverse primer < 400 > 12 aacgagacga cgacagactt t 21 < 210 > 13 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 144 - 3 p forward primer < 400 > 13 tacagtatag atgatgtact 20 < 210 > 14 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 144 - 3 p reverse primer < 400 > 14 aacgagacga cgacagactt t 21 < 210 > 15 < 211 > 18 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 320 e forward primer < 400 > 15 aaagctgggt tgagaagg 18 < 210 > 16 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 320 e reverse primer < 400 > 16 aacgagacga cgacagactt t 21 < 210 > 17 < 211 > 17 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 4516 forward primer < 400 > 17 gggagaaggg tcggggc 17 < 210 > 18 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > miR - 4516 reverse primer < 400 > 18 aacgagacga cgacagactt t 21 < 210 > 19 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > FOSL 1 forward primer < 400 > 19 agctgcagaa gcagaaggag 20 < 210 > 20 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > FOSL 1 reverse primer < 400 > 20 ggagttaggg agggtgtggt 20 < 210 > 21 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > PAX 5 forward primer < 400 > 21 ggaggagtga atcagcttgg 20 < 210 > 22 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > PAX 5 reverse primer < 400 > 22 ggcttgatgc ttcctgtctc 20 < 210 > 23 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > TCL 1 A forward primer < 400 > 23 gcctgggaga agttcgtgta 20 < 210 > 24 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > TCL 1 A reverse primer < 400 > 24 actaagcgcc agaaactgga 20